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ABSTRACT:

There is an increasing need to develop field immobilization techniques that allow
researchers to handle safely swift foxes (Vulpes velox) with minimal risk of stress or injury. We
immobilized captive swift foxes to determine the safety and effectiveness of ketamine hydrochloride and xylazine hydrochloride at different dosages. We attempted to determine appropriate
dosages to immobilize swift foxes for an adequate field-handling period based on three anesthesia
intervals (induction period, immobilization period, and recovery period) and physiologic responses
(rectal temperature, respiration rate, and heart rate). Between October 1998–July 1999, we conducted four trials, evaluating three different dosage ratios of ketamine and xylazine (2.27:1.2,
5.68:1.2, and 11.4:1.2 mg/kg ketamine:mg/kg xylazine, respectively), followed by a fourth trial
with a higher dosage at the median ratio (11.4 mg/kg ketamine:2.4 mg/kg xylazine). We found
little difference in induction and recovery periods among trials 1–3, but immobilization time
increased with increasing dosage (P⬍0.08). Both the immobilization period and recovery period
increased in trial 4 compared with trials 1–3 (Pⱕ0.03). There was a high variation in responses
of individual foxes across trials, making it difficult to identify an appropriate dosage for field
handling. Heart rate and respiration rates were depressed but all physiologic measures remained
within normal parameters established for domestic canids. We recommend a dosage ratio of 10
mg/kg ketamine to 1 mg/kg xylazine to immobilize swift foxes for field handling.
Key words: Immobilization, ketamine hydrochloride, swift fox, Vulpes velox, xylazine hydrochloride.
INTRODUCTION

In 1996, the US Fish and Wildlife Service (USFWS) determined that listing the
swift fox (Vulpes velox) under the 1973
Endangered Species Act was warranted
but precluded by higher priority actions.
However, the USFWS requested additional information about the species from state
and federal agencies for a continued status
review. This finding generated numerous
studies to gather information on swift fox
ecology and population biology, and
prompted the development of the Swift
Fox Conservation Team, comprised of
state and federal biologists within the historic range of the species. Development of
field immobilization techniques that allowed researchers to handle safely swift
foxes with minimal risk of stress or injury
became a high priority.
At present, no systematic study has been
published on the immobilization of swift
foxes. Seal and Kreeger (1987) suggested

immobilization of swift foxes using ketamine hydrochloride with promazine hydrochloride or xylazine hydrochloride with
atropine sulfate, and also mentioned the
need for a systematic study. Previous studies have demonstrated the effective use of
a combination of ketamine hydrochloride
(ketamine) and xylazine hydrochloride (xylazine) for immobilizing canids (Kreeger
and Seal, 1986; Kreeger et al., 1990; Travaini et al., 1992).
Ketamine affects the central nervous
system, inducing dissociative anesthesia
(Wright, 1983). Desirable characteristics
of ketamine as an immobilizing agent for
wild animals include the retention of normal reflex actions such as coughing and
swallowing, suitability for intramuscular
injection, non-cumulative effects, and a
wide safety margin allowing for general estimation of body weights (Ramsden et al.,
1976; Wright, 1983). Muscle rigidity occurs when ketamine is used alone, so it is
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TABLE 1. Least-squares means (LS) and standard errors (SE) for the duration of each time period (min) for
each trial dosage of ketamine hydrochloride (KET) and xylazine hydrochloride (XYL), October 1998–July
1999.

a
b

Trial

KET
(mg/kg)

XYL
(mg/kg)

KET : XYL

1
2
3
4

2.3
5.7
11.4
11.4

1.2
1.2
1.2
2.4

1.9
4.7
9.5
4.7

Induction
period

Immobilization
period

Recovery
period

n

LS ⫾ SE

LS ⫾ SE

LS ⫾ SE

13
14
13
13

6.3 ⫾ 1.4Aa
6.3 ⫾ 1.2A
3.6 ⫾ 1.2A
—b

12.9
31.1
40.6
64.2

⫾
⫾
⫾
⫾

4.6A
4.4B
4.6C
4.6D

29.1
29.9
32.7
47.9

⫾
⫾
⫾
⫾

4.8A
4.7A
4.8A
4.8B

Least-squares means within columns followed by a common letter are not significantly different (P ⱕ 0.10; Fisher’s LSD).
Data for the induction period for trial 4 were excluded from the ANOVA analysis because the data violated the assumption
of equal variances. Mean induction period time for trial 4 was 2.1 min (SE⫽0.04).

frequently used in combination with xylazine, a sedative analgesic and muscle relaxant (Fuller and Kuehn, 1983). Immobilization with a combination of ketamine
and xylazine results in a smooth and rapid
induction followed by a smooth but extended recovery (Kreeger and Seal, 1986).
We evaluated different dosages of these
combined drugs under controlled conditions to determine an appropriate dosage
range to immobilize swift foxes for an adequate field-handling period, while minimizing the recovery time.
MATERIALS AND METHODS

We captured swift foxes in Sherman and
Wallace counties in western Kansas (USA) in
August of 1996. We transported and held the
captured foxes in facilities at Northern Prairie
Wildlife Research Center in Jamestown, North
Dakota (USA, 46⬚52⬘N, 98⬚38⬘W). All procedures were reviewed and approved by the
Northern Prairie Wildlife Research Center Animal Care and Use Committee. Each fox was
paired with an unrelated mate and the pairs
were held in separate pens (approximately
3⫻5⫻1.5 m), with the exception of two males
who were held alone. Two den boxes, one
above ground and one below ground, were provided in each pen and foxes could dig dens to
1 m below ground. Foxes were fed daily with
frozen commercial canine food (R & R Feeds,
Ottertail, Minnesota, USA); water was provided
ad libitum. Each fox was immunized for rabies
(Defensor娂, SmithKline Beecham Animal
Health, West Chester, Pennsylvania, USA), canine coronavirus (FirstDose威 Pfizer Animal
Health, Exton, Pennsylvania, USA), canine distemper, canine parvovirus, infectious canine
hepatitis, leptospirosis, and parainfluenza (Van-

guard威 puppy5/L, Pfizer Animal Health, Exton,
Pennsylvania, USA). All foxes were periodically
treated for ecto- and endo-parasites (Ivomec威,
Merck, Inc., Rahway, New Jersey, USA; VetKem威, Flea & Tick Powder, Sandoz Agro, Inc.,
Des Plaines, Illinois, USA).
Fourteen adult swift foxes (ⱖ1 yr old; six females, eight males) were used in our study.
Four trials were conducted on each fox between October 1998–July 1999, based on four
different dosage ratios (Table 1) of a combination of ketamine (Ketaset威, Bristol Laboratories, Division of Bristol-Myers Co., Syracuse,
New York, USA) and xylazine (Rompun威, Haver-Lockhart Laboratories, Division of Bayvet
Corporation, Shawnee, Kansas, USA). We selected the dosages based on a red fox (Vulpes
vulpes) immobilization study by Kreeger et al.
(1990). We increased the dosage ratio in the
first three trials by increasing the ketamine administered and keeping the xylazine constant
(Table 1). In trial 4 we used the median dosage
ratio (trial 2) but increased the dosage.
Trials were conducted in a laboratory for ambient temperature control and to eliminate inconsistencies in surrounding disturbances. We
reduced the biological effects of stress from removing the foxes from holding pens by placing
the foxes in dog carriers within a dark, quiet
room for a minimum of 20 min prior to the
start of the trial.
Immediately prior to administering the immobilization drugs, swift foxes were weighed to
determine the amount of drug needed relative
to weight. Foxes were easily removed from the
dog carriers by covering them with a blanket
and then taking hold of the animal by the skin
on the back of the neck. Drugs were administered by intramuscular injection into the upper
right hindquarter of each animal and the time
of injection was recorded. Foxes were then
placed on a blanket in a cage (76⫻61⫻76 cm).
Once the foxes were safe to handle, their eyes
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were lubricated (sterile saline solution) and a
cloth was placed over their eyes to minimize
the risk of eye injuries from light and limit their
response to researchers.
We measured the duration of three periods
(induction, immobilization, and recovery) similar to other studies (Hash and Hornocker,
1980; Kreeger et al., 1990). Induction period
was defined as the time between initial injection and when the fox was fully immobilized
(i.e., head down and unresponsive to touch).
Immobilization period was the time between
the fox being unresponsive and the moment it
first elevated its head. Recovery was the time
between the fox spontaneously lifting its head
and recovery of all faculties, marked by its ability to walk back into the carrier, although its
behavior was not necessarily normal.
Once swift foxes were immobilized, we monitored rectal temperature to the nearest 0.5 C
once per minute with a digital thermometer.
For a 15 sec interval each minute, heart rate
was determined by auscultation (beats/min),
and respiratory rate was determined by observing thoracic expansion (breaths/min). These parameters were recorded until termination
throughout the immobilization period. Values
measured for heart and respiration rates were
multiplied by four to determine rate per minute. We determined the average temperature,
heart rate, and respiratory rate during the immobilization period for each fox in each trial.
Any physical reactions to the drug were noted
(e.g., vomiting, excessive salivation, compulsive
licking, muscle twitching).
Preliminary analysis did not indicate strong
positive or negative correlations among induction, immobilization, and recovery periods, so
we analyzed each of these three response variables separately. We used SAS PROC MIXED
(SAS Institute, 1989) to perform an analysis of
variance (ANOVA) in a randomized block design, with fox as a blocking factor, to compare
the durations of the induction, immobility, and
recovery periods (Littell et al., 1996). We used
the same procedure to compare mean physiologic responses (heart rate, respiration, and
body temperature). We used a Type I error rate
of ␣⫽0.10 and verified model assumptions using residual plots. If residual plots for a response variable did not follow a normal distribution, we applied a log transformation and repeated the ANOVA. When we detected differences among trials, we used Fisher’s LSD test
to conduct multiple comparisons and determine which trials differed (Milliken and Johnson, 1984).
RESULTS

Residual plots for each time period
showed no evidence of differences in re-

sponses between male and female foxes,
hence data from both sexes were pooled
together for the analysis. Data for the induction period did not follow a normal distribution and was log transformed. We
found no evidence of differences in induction time among trials 1–3 (F⫽2.23,
df⫽2,20, Pⱕ0.13; Table 1). Trial 4 was not
included in the analysis for the induction
period because the variances in these data
were heterogeneous to trials 1–3. Because
no difference was detected in the mean
induction times for trials 1–3, we calculated the overall mean induction time for the
three trials (x̄⫽5.2 min, SE⫽0.75, n⫽36).
The mean induction time for trial 4 was
2.1 min (SE⫽0.04, n⫽13). Although we
could not compare the mean induction
time for trials 1–3 with trial 4 statistically,
the 2.5 fold decrease in the mean induction time from trials 1–3 to trial 4 indicated a biological difference.
Immobilization period differed among
trials (F⫽32.2, df⫽3,36, Pⱕ0.0001), and
multiple comparisons indicated a progressive increase in the amount of time immobilized from trials 1–4 (Pⱕ0.08). We
also found strong evidence of differences
among trials for the recovery period
(F⫽3.58, df⫽3,36, Pⱕ0.02). Multiple comparisons indicated an increased recovery
time between trial 4 and trials 1–3
(円t円ⱖ2.29, df⫽36, Pⱕ0.03).
Foxes with less than five measurements
within trials were excluded from the analysis of mean physiologic responses. Heart
rate data were not normal and were log
transformed. Mean heart rate was different among trials (F⫽4.77, df⫽3,29,
Pⱕ0.008); multiple comparisons indicated
that mean heart rate was the same for trials 1, 2, and 4, but was higher in trial 3
(円t円ⱖ1.96, df⫽29, Pⱕ0.06; Table 2). Mean
respiration rate also differed among trials
(F⫽7.20, df⫽3,29, Pⱕ0.0009). Trial 1 had
a higher mean respiration rate than trials
2–4 (円t円ⱖ3.06, df⫽29, Pⱕ0.004), and trial
3 had a higher rate than trial 4 (円t円ⱖ1.73,
df⫽29, Pⱕ0.09). Finally, we found differences in mean body temperature among
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TABLE 2. Least-squares means (LS) and standard errors (SE) of physiologic responses for each trial, determined from the mean responses of individual foxes, measured each minute during the immobilization period
for each trial dosage of ketamine hydrochloride (KET) and xylazine hydrochloride (XYL), October 1998–July
1999.

Trial

1
2
3
4
a

KET
XYL
(mg/kg) (mg/kg)

2.3
5.7
11.4
11.4

1.2
1.2
1.2
2.4

Heart rate
(beats/min)
KET : XYL

1.9
4.7
9.5
4.7

n

7
13
13
13

Respiration rate
(breaths/min)

LS ⫾ SE

90.9
84.9
104.5
92.0

n

⫾
⫾ 4.2A
⫾ 4.2B
⫾ 4.2A

5.5Aa

7
13
13
13

LS ⫾ SE

35.3
27.9
29.6
27.1

⫾
⫾
⫾
⫾

2.4A
2.1BC
2.1B
2.1BC

Temperature
(C)
n

4
13
13
13

LS ⫾ SE

39.5
39.4
38.4
38.2

⫾
⫾
⫾
⫾

0.3A
0.2A
0.2B
0.2B

Least-squares means within columns followed by a common letter are not significantly different (P ⱕ 0.10; Fisher’s LSD).

trials (F⫽13.26, df⫽3,26, Pⱕ0.0001), with
temperatures higher in trials 1–2 than in
trials 3–4 (円t円ⱖ3.13, df⫽26, Pⱕ0.004).
Four foxes in trial 1 experienced adverse
effects during immobilization, including excessive salivation, compulsive licking, vomiting, and muscle twitching. In trial 2, four
foxes had compulsive licking, vomiting, or
both. One fox in trial 4 experienced muscle
twitching during induction. No physical reactions were noted during trial 3.
DISCUSSION

Immobilization of swift foxes with a
combination of ketamine and xylazine resulted in a smooth induction and smooth
but extended recovery. We experienced no
deaths or serious adverse effects (e.g., seizures, overheating) sometimes associated
with this drug combination (Wright, 1982).
We found it difficult to identify an optimal
dosage of ketamine and xylazine for swift
foxes because of the large variation in responses of individual foxes across trials.
However, we were able to establish guidelines for selecting an appropriate dosage
with adequate handling time and minimal
recovery time.
Six of 13 swift foxes in trial 1 were immobilized ⬍10 min, indicating that the
dosage of 2.27 mg/kg ketamine and 1.2
mg/kg xylazine was too low for an adequate field-handling period. Mean induction and recovery periods were similar for
the dosage ratios tested in trials 1–3, but
the immobilization period increased.

Therefore, the ketamine to xylazine ratio
of 9.5:1.0 in trial 3 provides the lengthiest
handling period while minimizing induction and recovery time (Table 1). In trial
4, the mean immobilization period was
⬎60 min, beyond the time normally necessary for field handling, and the mean recovery period was significantly lengthened.
In general, the physiologic measurements in the four trials did not indicate a
health risk and were not a factor in identifying a suitable dosage. However, swift
foxes in trials 1 and 2 did experience increased incidences of salivation, compulsive licking, vomiting, and muscle twitching. Food often was available to foxes because of their food caching behavior, thus
the vomiting may be attributed to some
foxes eating immediately prior to a trial.
Womer and Richards (1990) reported a
mean heart rate of 141 (beats/min)⫾6.2
and a mean respiratory rate of 48 (breaths/
min)⫾5.2 for non-restrained swift foxes.
Heart rate and respiration rate during the
trials were comparatively depressed, but
were still within a range of 72–200 beats/
min and 11–37 breaths/min established for
domestic canids (Altman and Dittmer,
1974). Although mean rectal temperature
statistically differed between trials 1–2 and
trials 3–4, all trials varied less than a degree from the mean rectal temperature of
39 C⫾0.2 reported by Womer and Richards (1990).
Overall, we recommend ketamine-xylazine as a safe, effective drug combination
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for immobilizing adult swift foxes in the
field. However, we did not include pregnant females in our study, and we found
no studies indicating whether the drug
combination was safe for immobilizing
pregnant swift foxes. Travaini et al. (1992)
reported successful births by three pregnant red foxes after being immobilized in
late winter, but further study is needed to
determine the effects of ketamine-xylazine
on birthing success in swift foxes. We suggest using a dosage of approximately 10
mg/kg ketamine and 1 mg/kg xylazine for
an average handling time of 40 min.
Greater ratios may also be effective but
were not tested in our study. Researchers
may want to consider using a higher dosage than may seem necessary, because of
a potentially high response variance among
individual swift foxes. For field procedures, this variance may be compounded
by capture stress (Kreeger and Seal, 1986),
and the variation in nutritional and health
condition of wild swift foxes (Travaini et
al., 1992).
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